Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Submit a News Story
Research Finding Could Lead to Targeted Therapies for IBD
Tuesday, December 01, 2015
Findings published online in Cell Reports.
A Cellular Symphony Responsible for Autoimmune Disease
Monday, November 30, 2015
Broad Institute researchers have used a novel approach to increase our understanding of the immune system as a whole.
MD Anderson Receives $22.2M in CPRIT Research Funding
Friday, November 27, 2015
The University of Texas MD Anderson Cancer Center was awarded more than $22 million in research grants this week from the Cancer Prevention and Research Institute of Texas (CPRIT).
Genetic Basis of Fatal Flu Side Effect Discovered
Friday, November 27, 2015
A group of people with fatal H1N1 flu died after their viral infections triggered a deadly hyperinflammatory disorder in susceptible individuals with gene mutations linked to the overactive immune response, according to a recent study.
Developing Drug Resistance may be a Matter of Diversity for Tuberculosis
Tuesday, November 24, 2015
Researchers have probed the bacteria that causes tuberculosis, Mycobacterium tuberculosis, to learn more about how individual bacterial cells change and adapt while in the human body.
Surprising Trait Found in Anti-HIV Antibodies
Monday, November 23, 2015
Scientists at The Scripps Research Institute (TSRI) have new weapons in the fight against HIV.
Nuevolution A/S Appoints Professor Mark C. Genovese as Advisor
Saturday, November 21, 2015
Appointment to support the companies’ pre-clinical and clinical efforts in inflammatory diseases.
Some Gut Microbes May Be Keystones of Health
Monday, November 16, 2015
University of Oregon scientists have found that strength in numbers doesn’t hold true for microbes in the intestines. A minority population of the right type might hold the key to regulating good health.
Abcam Acquires AxioMx
Friday, November 13, 2015
AxioMx provides a unique, cost-effective, and proprietary platform to produce recombinant monoclonal antibodies complementing Abcam's existing innovative production capabilities.
Showing Results 91 - 100 of 1726
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
2,900+ scientific and medical posters
4,200+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!